鼻窦恶性肿瘤治疗相关并发症分析
该回顾性研究纳入2005至2018年129例鼻窦恶性肿瘤患者,评估治疗后并发症与放疗毒性。术后并发症发生率为10.4%(12例),高级别(3-5级)放疗毒性为21.0%(22例);放疗后慢性鼻窦炎需FESS和症状性鼻塞需手术清创各占20%(21例)。结论认为这些并发症常见,尤其在化放疗患者中更频繁。
要点
- 鼻窦恶性肿瘤治疗后慢性鼻窦炎和鼻塞各占20%,需手术干预。
- 高级别放疗毒性发生率为21.0%,术后并发症为10.4%。
- 化放疗患者并发症比单纯手术者更常见。
核心结论
- 鼻窦恶性肿瘤根治性治疗后鼻塞和慢性鼻窦炎等并发症常见,应关注幸存者生活质量。
- 这些并发症在化放疗患者中比单纯手术患者更频繁。
研究设计与样本
- 回顾性分析2005至2018年三级转诊机构129例鼻窦恶性肿瘤患者。
- 主要结局为治疗细节、病理、治疗后并发症和放疗毒性。
主要发现
- 平均年龄58.4岁(中位61,范围19-94)。
- 24例仅手术,46例手术加放疗,47例手术加化放疗,14例根治性化放疗。
- 术后并发症发生率10.4%(n=12)。
- 高级别(3-5级)放疗毒性发生率21.0%(n=22)。
关键数值与推荐
- 放疗后20%(n=21)患者需功能性内镜鼻窦手术治疗慢性鼻窦炎。
- 放疗后20%(n=21)患者需手术清创治疗症状性鼻塞。
临床怎么用
- 鼻窦恶性肿瘤治疗后应常规评估鼻塞和慢性鼻窦炎,必要时手术干预。
- 对接受化放疗的患者需更密切监测高级别放疗毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sinonasal malignancies are a rare, heterogeneous group of tumors that often present at an advanced stage and require multimodal therapy. The presence of high-grade toxicity and sinonasal complications after treatment can negatively impact quality of life. In this study we aim to describe posttreatment morbidity in patients with sinonasal malignancy. METHODS: A retrospective analysis of all patients treated for sinonasal malignancy was conducted from 2005 to 2018 at a tertiary referral institution. A total of 129 patients met the inclusion criteria. Primary outcomes were treatment details, pathology, posttreatment complications, and radiation toxicity. Fisher's exact test, chi-square test, and Student t test were used for statistical analysis. RESULTS: Mean age was 58.4 (median, 61; range, 19-94) years. After diagnosis, 24 patients had surgery alone, 46 had surgery with radiation alone, 47 had surgery with chemoradiation, and 14 received definitive chemoradiation. Overall, 10.4% (n = 12) of patients had postoperative complications, and 21.0% (n = 22) had high-grade (grade 3-5) radiation toxicity. After radiation, 20% (n = 21) of patients had chronic sinusitis requiring functional endoscopic sinus surgery and 20% (n = 21) had symptomatic nasal obstruction requiring operative debridement. CONCLUSION: Sinonasal complications, including nasal obstruction and chronic sinusitis, occur frequently after definitive treatment of sinonasal malignancy and should be addressed when considering quality of life in survivors. These complications occur more frequently in patients who undergo chemoradiation as opposed to surgery alone.
引用
- Patel J, Chitguppi C, Vimawala S, et al. Treatment-related morbidity in patients treated for sinonasal malignancy. Int Forum Allergy Rhinol. 2020. PMID: 31930702. doi:10.1002/alr.22509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。